 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Dec 20, 2021 |
| Title |
Loss-of-function ROX1 mutations suppress the fluconazole susceptibility of upc2A∆ mutation in Candida glabrata, implicating additional positive regulators of ergosterol biosynthesis |
| Organism |
Nakaseomyces glabratus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Two of the major classes of antifungal drugs in clinical use target ergosterol biosynthesis. Despite its importance, our understanding of the transcriptional regulation of ergosterol biosynthesis genes in pathogenic fungi is essentially limited to the role of hypoxia and sterol-stress induced transcription factors such as Upc2 and Upc2A as well as homologs of Sterol Response Element Binding (SREB) factors. To identify additional regulators of ergosterol biosynthesis in Candida glabrata, an important human fungal pathogen with reduced susceptibility to ergosterol biosynthesis inhibitors relative to other Candida spp., we used a serial passaging strategy to isolate suppressors of the fluconazole hypersusceptibility of a upc2A∆ deletion mutant. This led to the identification of loss of function mutants in two genes: ROX1, the homolog of a hypoxia gene transcriptional suppressor in Saccharomyces cerevisiae, and CST6, a transcription factor that is involved in the regulation of carbon dioxide response in C. glabrata. Here, we describe a detailed analysis of the genetic interaction of ROX1 and UPC2A. In the presence of fluconazole, loss of Rox1 function restores ERG11 expression to the upc2A∆ mutant and inhibits the expression of ERG3 and ERG6, leading to increased levels or ergosterol and decreased levels of the toxic sterol, 14α methyl-ergosta-8,24(28)-dien-3β, 6α-diol, relative to upc2A∆. Our observations establish that Rox1 is a negative regulator of ERG gene biosynthesis and indicate that a least one additional positive transcriptional regulator of ERG gene biosynthesis must be present in C. glabrata.
|
| |
|
| Overall design |
C. glabrata mRNA expression of upc2A∆, rox1∆, and upc2a∆ rox1∆ were compared against WT in both YPD medium and YPD plus fluconazole media. Within each comparison, wild-type cells represent baseline expression and each strain has three biological replicates.
|
| |
|
| Contributor(s) |
Ollinger TL, Vu B, Murane D, Parker J, Simonicova L, Doorley LA, Stamnes MA, Kelley SL, Rogers PD, Moye-Rowley WS, Krysan DJ |
| Citation(s) |
34935446 |
| |
| Submission date |
Dec 17, 2021 |
| Last update date |
Jan 10, 2022 |
| Contact name |
Damian J Krysan |
| E-mail(s) |
[email protected]
|
| Organization name |
University of Iowa Hospitals and Clinics
|
| Department |
Division of Pediatrics & Infectious Disease
|
| Lab |
Krysan
|
| Street address |
25 South Grand, 2040 ML
|
| City |
Iowa City |
| State/province |
IA |
| ZIP/Postal code |
52242 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL31108 |
Illumina MiSeq ([Candida] glabrata) |
|
| Samples (25)
|
|
| Relations |
| BioProject |
PRJNA789874 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE191145_Supplementary_Table_2.xlsx |
1.8 Mb |
(ftp)(http) |
XLSX |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data are available on Series record |
|
|
|
|
 |
Less...
More...